Giant Cell Arteritis
📧 Sign up to get email alerts when something new happens for Giant Cell Arteritis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-21EMA Authorised: Tuyory — Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)
EMA authorised Tuyory from Chemical Works of Gedeon Richter Plc. for multiple indications including rheumatoid arthritis, juvenile arthritis…
-
EMA approval · 2026-08-19EMA Authorised: Tyenne (tocilizumab) — Fresenius Kabi Deutschland GmbH
Tyenne (tocilizumab) has been authorised by the EMA for multiple indications including rheumatoid arthritis, cytokine release syndrome, juve…
-
EMA approval · 2026-08-13EMA Authorised: RoActemra (tocilizumab) — Roche Registration GmbH
RoActemra (tocilizumab) has been authorised by the European Medicines Agency for multiple indications including rheumatoid arthritis, juveni…
-
EMA approval · 2026-07-15EMA Authorised: Rinvoq (upadacitinib) — AbbVie Deutschland GmbH & Co. KG
Rinvoq (upadacitinib) has been authorised by the EMA for multiple inflammatory diseases including rheumatoid arthritis, psoriatic arthritis,…
-
EMA approval · 2026-06-15EMA Authorised: Tuyory — Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)
Tuyory has been authorised by the EMA for multiple indications including rheumatoid arthritis, juvenile arthritis, cytokine release syndrome…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-06-09EMA Authorised: Rinvoq (upadacitinib) — AbbVie Deutschland GmbH & Co. KG
EU authorization of Rinvoq (upadacitinib) by AbbVie Deutschland for multiple inflammatory indications including rheumatoid arthritis, psoria…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial [Phase 3]
This document describes a Phase 3 multicenter randomized trial comparing methotrexate versus tocilizumab for Giant Cell Arteritis, currently…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Chewing Gum Test for the Diagnosis of Giant Cell Arteritis (Horton's Disease) - ChewingHort [NA]
A completed clinical trial evaluating a chewing gum diagnostic test for Giant Cell Arteritis (Horton disease).
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: The VGR GCA Cohort: Ultrasound, Biopsy and Biomarkers - Novel Methods for Diagnosis, Monitoring and Prognosis in Giant Cell Arteritis.
This clinical trial update describes the VGR GCA Cohort, evaluating ultrasound, biopsy, and biomarkers as novel methods for diagnosing, moni…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis [Phase 2]
Phase 2 clinical trial evaluating discontinuation versus dose reduction of tocilizumab in well-controlled giant cell arteritis is currently …
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Giant Cell Arteritis and Anakinra Trial [Phase 3]
Phase 3 trial evaluating anakinra for Giant cell arteritis has been terminated.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Early Temporal Dynamics of Optic Nerve Sheath Diameter After Therapy in GCA
This clinical trial update describes early changes in optic nerve sheath diameter after therapy in giant cell arteritis, with the study curr…
-
EMA approval · 2026-04-01EMA Authorised: RoActemra (tocilizumab) — Roche Registration GmbH
EMA authorised RoActemra (tocilizumab) for multiple indications, including rheumatoid arthritis, juvenile idiopathic arthritis, cytokine rel…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR [Phase 1]
Phase 1 study evaluating the pharmacokinetics, safety, and tolerability of intravenous secukinumab in patients with Giant Cell Arteritis or …
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA) [Phase 3]
The document reports the completion of a Phase 3 trial evaluating secukinumab versus placebo, in combination with a glucocorticoid taper, fo…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NIAMS sponsors a clinical trial to study the natural history, pathogenesis, and outcomes of idiopathic systemic vasculitis, with recruiting …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
This clinical trial investigates whether ultrasonographic temporal artery lesions are associated with relapse in patients with giant cell ar…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency [Phase 4]
Phase 4 clinical trial evaluating supplemental hydrocortisone during stress in patients with prednisolone-induced adrenal insufficiency; cur…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Study of the T CD8 Immune Response in Horton's Disease
A completed clinical trial investigating the CD8+ T cell immune response in Giant Cell Arteritis (Horton’s disease).
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases [Phase 1, Phase 2]
This clinical trial update reports ongoing Phase 1/2 studies evaluating the Ga-68-labeled NI-FAPI-04 PET/CT imaging agent for fibroblast act…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: TArget Trial Emulation Comparing Effectiveness of Tocilizumab vs Methotrexate In Corticosteroid-Treated GCA Patients
A completed trial comparing tocilizumab to methotrexate for corticosteroid-treated giant cell arteritis has been completed.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of secukinumab in adults with new-onset giant cell arteritis who are in clinical remissio…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Rheumatology Patient Registry and Biorepository
This Clinical Trial Update describes a Yale University-led rheumatology patient registry and biorepository that is currently recruiting to c…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica
This clinical trial update describes a study funded by Hôpital NOVO investigating the association between sacroiliitis/axial spondyloarthrit…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Evaluation of PET/CT of Cephalic Arteries for the Diagnosis of Giant Cell Arteritis
This clinical trial evaluated PET/CT imaging of the cephalic arteries for diagnosing giant cell arteritis. The study status is completed.